Gracell Biotechnologies (GRCL)
NASDAQ:GRCL
US Market
Holding GRCL?
Track your performance easily

Gracell Biotechnologies (GRCL) Balance Sheet

134 Followers

Gracell Biotechnologies Balance Sheet

Gracell Biotechnologies's total assets for Q4 2022 were $240.14M, a decrease of -86.94% from the previous quarter. GRCL total liabilities were $40.67M for the fiscal quarter, a -86.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 240.14M$ 2.06B$ 964.95M$ 412.22M$ 148.52M
Total Liabilities
$ 40.67M$ 232.77M$ 145.29M$ 156.86M$ 146.13M
Total Equity Gross Minority
$ 199.47M$ 1.83B$ 819.66M$ 255.36M$ 2.38M
Total Capitalization
$ 1.38B$ 1.88B$ 871.59M$ 394.05M$ 141.08M
Preferred Stock Equity
--$ 1.41B$ 547.84M$ 83.40M
Capital Lease Obligations
--$ 0.00--
Currency in USD

Gracell Biotechnologies Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis